<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of pregnancy in patients of advanced age</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of pregnancy in patients of advanced age</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of pregnancy in patients of advanced age</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ruth C Fretts, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Louise Wilkins-Haug, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alana Chakrabarti, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 13, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients who delay childbearing are at increased risk of pregnancy complications, including ectopic pregnancy, spontaneous abortion, fetal chromosomal abnormalities, some congenital anomalies, placenta previa, gestational diabetes, preeclampsia, and cesarean birth. Such complications may, in turn, lead to preterm birth. There is also an increased risk of perinatal mortality. Benefits of delayed childbearing include that older couples tend to be more emotionally mature and financially stable than when they were younger. </p><p>Providing information to all patients of childbearing age about the obstetric risks of advanced maternal age can help them make informed decisions about the timing of childbearing. </p><p>This topic will address the management of pregnancy in patients of advanced age, which is generally agreed upon as age ≥35 years. Related topics on the effects of advanced age on pregnancy and fertility are presented separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/421.html" rel="external">"Effects of advanced maternal age on pregnancy"</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/111561.html" rel="external">"Evaluation and management of infertility in females of advancing age"</a>.)</p><p></p><p class="headingAnchor" id="H2069686041"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H1276452278"><span class="h2">Advanced maternal age</span><span class="headingEndMark"> — </span>The age cut-off for advanced maternal age (AMA) pregnancy is not uniformly defined. Historically, AMA was defined as maternal age ≥35 years based on the convergence of the risk of fetal Down syndrome and the risk of amniocentesis to assess for Down syndrome. Other studies have defined AMA as age 40 or greater. </p><p class="headingAnchor" id="H520445554"><span class="h2">Very advanced maternal age and implications</span><span class="headingEndMark"> — </span>A category of "very advanced maternal age" has been proposed for patients ≥45 years or ≥50 years, depending on the study [<a href="#rid1">1,2</a>]. Patients of very advanced maternal age have higher complication rates, multiple gestation rates, and an increase in rates of preterm birth and fetal growth restriction  (<a class="graphic graphic_figure graphicRef110512" href="/z/d/graphic/110512.html" rel="external">figure 1</a>) [<a href="#rid3">3</a>]. A cohort study comparing patients ≥48 years of age with those ≤47 years of age reported that patients ≥48 years had a nearly threefold increase in cesarean birth, a fourfold increase in gestational diabetes, a sixfold increase in the risk of requiring blood transfusion, and a 33-fold increase in intensive care unit admission, after controlling the data for multiple gestation [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H2760397405"><span class="h1">INCIDENCE OF BIRTHS TO OLDER PATIENTS</span><span class="headingEndMark"> — </span>There has been a notable shift to pregnancy at older maternal ages, particularly in resource-rich countries [<a href="#rid4">4</a>]. As an example, in the United States, the rates of pregnancy have decreased for patients under 30 years and increased for patients ages 30 and above from 1990 to 2015  (<a class="graphic graphic_table graphicRef110497" href="/z/d/graphic/110497.html" rel="external">table 1</a> and <a class="graphic graphic_figure graphicRef110511" href="/z/d/graphic/110511.html" rel="external">figure 2</a>) [<a href="#rid5">5</a>]. </p><p>At a time when patients are delaying childbearing, the availability of assisted reproductive technologies for older patients has allowed patients to extend their reproductive options. In the United States, there were 840 births to patients ages ≥50 years in 2017, an increase from 677 births in 2013 [<a href="#rid6">6</a>]. </p><p class="headingAnchor" id="H1235663974"><span class="h1">RISK OF PREGNANCY LOSS</span><span class="headingEndMark"> — </span>The risk of pregnancy loss associated with advancing maternal age has been well recognized. Population-based studies have reported pregnancy loss rates up to 40 percent in 35- to 44-year-old patients and 60 to 65 percent in patients &gt;45 years [<a href="#rid7">7,8</a>]. In addition, the increased risk of pregnancy loss extends beyond the first trimester. In a British study of 76,000 singleton pregnancies with a live fetus, the pregnancy loss rates after 11 weeks of gestation were 1.2 percent for patients under the age of 35, 1.6 percent in patients 35 to 39 years of age, and 2.7 percent in patients 40 years of age or older  (<a class="graphic graphic_figure graphicRef110507" href="/z/d/graphic/110507.html" rel="external">figure 3</a>) [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3164031591"><span class="h1">SPECIFIC PRENATAL CARE ISSUES</span><span class="headingEndMark"> — </span>In addition to routine prenatal assessments, we discuss the following issues with patients of advanced maternal age. (See  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a>.)</p><p class="headingAnchor" id="H2986345499"><span class="h2">First and second trimester</span><span class="headingEndMark"> — </span>The following suggestions apply to patients ≥35 years of age at the estimated date of delivery:</p><p class="bulletIndent1"><span class="glyph">●</span>Age and obesity are risk factors for development of type 2 diabetes mellitus, as well as gestational diabetes [<a href="#rid10">10</a>]. Since type 2 diabetes may not have been recognized periconceptionally, screening older obese gravida for gestational diabetes in the first trimester, as well as later in pregnancy, is reasonable. (See  <a class="medical medical_review" href="/z/d/html/6797.html" rel="external">"Gestational diabetes mellitus: Screening, diagnosis, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The risk of fetal aneuploidy based on maternal age should be reviewed  (<a class="graphic graphic_table graphicRef70032" href="/z/d/graphic/70032.html" rel="external">table 2</a>). Most data relate to risk of trisomy 21 or composite risk of any aneuploidy, but some data are also available for maternal age-specific prevalence of trisomies 13 and 18 for patients aged 16 to 45 [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1">Testing for fetal aneuploidy can be invasive or noninvasive. Invasive testing, which involves amniocentesis and chorionic villus sampling to obtain fetal/placental cells, is diagnostic. Noninvasive testing of maternal blood (for either specific analyte levels or cell-free DNA), with or without ultrasound examination, is a screening test and requires follow-up testing of patients with screen-positive results. (See  <a class="medical medical_review" href="/z/d/html/426.html" rel="external">"Down syndrome: Overview of prenatal screening"</a> and  <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">"Diagnostic amniocentesis"</a> and  <a class="medical medical_review" href="/z/d/html/449.html" rel="external">"Chorionic villus sampling"</a> and  <a class="medical medical_review" href="/z/d/html/447.html" rel="external">"Sonographic findings associated with fetal aneuploidy"</a> and  <a class="medical medical_review" href="/z/d/html/458.html" rel="external">"Prenatal screening for common aneuploidies using cell-free DNA"</a>.)</p><p></p><p class="bulletIndent1">In patients of advanced maternal age, noninvasive prenatal screening to measure cell-free DNA in maternal blood is becoming the preferred test because it has both higher sensitivity and a lower false-positive rate than analyte/ultrasound screening and it is safer than invasive diagnostic testing  (<a class="graphic graphic_table graphicRef110510" href="/z/d/graphic/110510.html" rel="external">table 3</a>) [<a href="#rid12">12</a>]. Down syndrome screening tests have both higher detection rates and higher false-positive rates in older patients than in younger patients because of the higher prevalence of Down syndrome in offspring of older patients. (See  <a class="medical medical_review" href="/z/d/html/458.html" rel="external">"Prenatal screening for common aneuploidies using cell-free DNA"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Given the increased risk of congenital fetal anomalies in older patients, a detailed second-trimester ultrasound examination to assess for significant structural anomalies (particularly cardiac defects) is reasonable and is now recommended as a routine part of prenatal care in all pregnant patients. (See  <a class="medical medical_review" href="/z/d/html/421.html" rel="external">"Effects of advanced maternal age on pregnancy", section on 'Congenital malformations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Events that occur with increased frequency in older gravidae include hypertensive disease and preeclampsia, placenta previa, gestational diabetes, and abruption [<a href="#rid13">13-15</a>]. We educate patients about these conditions as well as the implications of preterm birth, which can be required in management of some of these complications. </p><p></p><p class="bulletIndent1">For patients &gt;35 years of age <strong>and</strong> at least one other moderate risk factor (eg, nulliparity, body mass index [BMI] &gt;30 kg/m<sup>2</sup>, family history of preeclampsia in a mother or sister, Black race), we recommend low-dose <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> for preeclampsia prevention. This is consistent with US Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines [<a href="#rid16">16,17</a>], and is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Selecting patients at high risk of developing preeclampsia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient's risk for adverse outcome, including preterm birth/low birth weight, intrauterine growth restriction, and stillbirth, should be assessed by considering not only her age, but also the presence or absence of concomitant risk factors such as hypertension, diabetes, obesity, low socioeconomic status, Black race, and previous pregnancy complicated by growth restriction or preterm birth.</p><p></p><p class="headingAnchor" id="H1604910637"><span class="h2">Third trimester</span><span class="headingEndMark"> — </span>As there are no large, randomized trials that have examined the efficacy of routine antepartum testing in patients ages 35 and older, there remains no consensus on the management of late pregnancy for these patients. One strategy is to stratify patients based on their risk factors, such as age and parity, and to consider other factors that might influence risk, such as obesity and race [<a href="#rid18">18</a>]. </p><p>For pregnant patients ages 35 years and older, we obtain an ultrasound examination at 36 to 37 weeks of gestation to assess fetal growth and amniotic fluid volume. Some centers perform this ultrasound examination earlier (eg, 32 to 36 weeks) for selected patients (eg, 40 years and older, BMI &gt;30 kg/m<sup>2</sup>). We then perform twice weekly antepartum testing (alternating between a nonstress test and a biophysical profile) and ask patients to monitor daily fetal movement (kick counts) until delivery. We emphasize the importance of fetal movement as a sign of fetal well-being and encourage all of our patients to report decreased fetal movement in a timely fashion. If at any point this testing is not reassuring, then additional testing or induction of labor is warranted. (See  <a class="medical medical_review" href="/z/d/html/457.html" rel="external">"Overview of antepartum fetal assessment"</a> and  <a class="medical medical_review" href="/z/d/html/444.html" rel="external">"Decreased fetal movement: Diagnosis, evaluation, and management"</a>.) </p><p>A retrospective cohort study of over 4400 patients reported that by following a protocol for pregnant patients ≥35 years that included weekly biophysical profile testing beginning at 36 weeks of gestation and induction of labor by 41 weeks of gestation, the risk of stillbirth ≥36 weeks gestation was the same among advanced maternal age and non-advanced maternal age patients [<a href="#rid19">19</a>]. For patients who are 35 years of age and older who have additional risk factors, such as primiparity or obesity or who are Black, we generally start testing in a way that is convenient for the patient, alternating nonstress tests with ultrasounds weekly at 36 weeks.</p><p class="headingAnchor" id="H1690179516"><span class="h2">Risks of stillbirth versus delivery</span><span class="headingEndMark"> — </span>The risk of stillbirth increases with increasing maternal age such that patients ≥40 years of age have the same risk of stillbirth at 39 weeks of gestation as patients in their mid-20s have at 41 weeks of gestation [<a href="#rid20">20,21</a>]. In addition to advancing age, parity also impacts the risk of stillbirth, with primiparous patients having a greater risk at each gestational age compared with multiparous patients. A population-based study including over five million births reported the risk of stillbirth after 37 weeks of gestation in primiparous and multiparous patients less than 35 years of age was 1/270 and 1/775, respectively; for patients 35 to 39 years of age, it was 1/156 and 1/502, respectively; and for patients 40 years of age or older, it was 1/116 and 1/304, respectively [<a href="#rid22">22</a>]. In this study, Black patients had a higher risk of stillbirth at 37 weeks of gestation or longer at all maternal ages. Black patients 40 years or older were the highest risk group, with a 2.45-fold increase in stillbirth risk at 37 weeks or longer compared with White patients younger than 35 years of age (lowest risk group). Thus older patients at term and their providers must balance the benefits of remaining pregnant and waiting for spontaneous labor against the risk of stillbirth: </p><p class="bulletIndent1"><span class="glyph">●</span>In a national cohort study of over 829,000 births from 2000 through 2012, the risk of stillbirth after 37 weeks of gestation fell as the frequency of induction of labor increased [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective database review of over 700,000 deliveries between 37 and 43 weeks of gestation in Scotland from the time period of 1985 to 1996 reported the lowest cumulative probability of perinatal death at 38 weeks of gestation [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A trial comparing labor induction with expectant management in patients ages 35 years or older reported no significant difference in the risk of cesarean section or neonatal outcomes, including birth weight &lt;2500 g, Apgar score of 4 to 7, umbilical-cord blood arterial pH &lt;7.00, or neonatal intensive care unit admission [<a href="#rid25">25</a>]. Of note, the study was not adequately powered to assess the risk of perinatal mortality.</p><p></p><p>Based on the above data, we favor delivery in the 39<sup>th</sup> week of gestation for patients ages 35 years and older because of the increased risk of stillbirth beyond this gestational age, the diminishing reproductive options for patients in this age group, and the low risk of neonatal morbidity/mortality at this gestational age [<a href="#rid21">21,22,26</a>]. We more strongly favor induction at 39 weeks of gestation for patients who are ≥35 years and primiparous, ≥39 years of age, of Black race, or who have additional risk factors for stillbirth such as obesity. That said, we discuss both the options of induction and ongoing surveillance with these patients and respect the patient's preference regarding timing and type of intervention. </p><p>Patients who decline induction are managed with twice weekly testing and daily kick counts until spontaneous labor, nonreassuring testing, or 41 weeks of gestation (when induction is typically recommended for late-term gestation) is achieved [<a href="#rid27">27</a>]. For patients ≥40 years, we generally discourage expectant management (with surveillance) beyond 40 weeks of gestation. </p><p class="headingAnchor" id="H3779742170"><span class="h3">Induction of labor</span><span class="headingEndMark"> — </span>While induction of labor appears to reduce the risk of stillbirth, concerns have been raised that increasing use of induction will increase the rates of cesarean birth, which has its own risks. However, the data do not support such increases for all patients or patients of advanced maternal age [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/4476.html" rel="external">"Induction of labor with oxytocin", section on 'Risk-reducing induction'</a>.)</p><p>In a meta-analysis of four studies including over 2500 patients comparing induction of labor versus expectant management at term for patients ≥35 years of age, there was no statistically significant difference in cesarean birth rates between the induction and expectant management groups [<a href="#rid30">30</a>]. In a trial that randomly assigned over 600 patients ≥35 years of age to either induction of labor between 39+0 and 39+6 weeks of gestation or to expectant management, the cesarean birth and operative vaginal birth rates were similar between the two groups [<a href="#rid25">25</a>]. There were also no differences in the rates of adverse maternal or neonatal outcomes. No maternal or infant deaths occurred in either group. A retrospective cohort study of over 26,000 births reported that, for patients of advanced maternal age, delivery between 38+5<sup> </sup>and 39+6<sup> </sup>weeks optimized the balance among maternal cesarean birth rate, neonatal intensive care unit admission rate, maternal third- and fourth-degree perineal laceration rates, and newborn Apgar ≤6 [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H2843033684"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114191.html" rel="external">"Society guideline links: Female infertility"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112560.html" rel="external">"Society guideline links: General prenatal care"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Advanced maternal age (AMA) is generally considered as maternal age ≥35 years and is based on the convergence of the risk of fetal Down syndrome and the risk of amniocentesis to assess for Down syndrome; other definitions (eg, age ≥40 years) are sometimes used. (See <a class="local">'Advanced maternal age'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Very advanced maternal age is generally considered as maternal age ≥45 years or ≥50 years, depending on the study. (See <a class="local">'Very advanced maternal age and implications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Pregnancy complications that occur with increased frequency in older gravidae include: ectopic pregnancy, spontaneous abortion, fetal chromosomal abnormalities, some congenital anomalies, placenta previa, gestational diabetes, preeclampsia, and cesarean birth. Such complications may, in turn, result in preterm birth. There is also an increased risk of perinatal mortality. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management in the</strong> <strong>first and second trimesters</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Testing for fetal aneuploidy</strong> – For pregnant patients ≥35 years of age at the estimated date of delivery, we suggest offering prenatal diagnosis or screening for aneuploidy and a detailed second trimester ultrasound examination (18 to 20 weeks of gestation) to look for significant structural anomalies (particularly cardiac defects) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'First and second trimester'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">Aspirin</a><strong> prophylaxis</strong> – For patients &gt;35 years of age <strong>and</strong> at least one other moderate risk factor (eg, nulliparity, body mass index [BMI] &gt;30 kg/m<sup>2</sup>, family history of preeclampsia in a mother or sister, Black race), we recommend low-dose aspirin for preeclampsia prevention. This is discussed in detail separately. (See <a class="local">'First and second trimester'</a> above and  <a class="medical medical_review" href="/z/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Selecting patients at high risk of developing preeclampsia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management in the</strong> <strong>third trimester</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fetal testing</strong> – We obtain an ultrasound examination at 36 to 37 weeks of gestation to assess fetal growth and amniotic fluid volume. We then perform twice weekly antepartum testing and ask patients to monitor daily fetal movement (kick counts) until delivery. Earlier testing (32 to 36 weeks) may be performed for selected patients (eg, 40 years and older, BMI &gt;30 kg/m<sup>2</sup>). (See <a class="local">'Third trimester'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Timing of</strong> <strong>delivery</strong> – For pregnant patients ≥40 years of age at the estimated date of delivery, we suggest induction of labor at 39 weeks of gestation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We also favor this approach in patients ≥35 but &lt;40 years. We also discuss the alternative of ongoing close fetal and maternal surveillance and respect the patient's preference regarding timing and type of intervention. However, we generally discourage expectant management with close surveillance beyond 40 weeks of gestation. (See <a class="local">'Risks of stillbirth versus delivery'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Pregnancy at very advanced maternal age: a UK population-based cohort study. BJOG 2016.</a></li><li><a class="nounderline abstract_t">Waldenström U, Cnattingius S, Vixner L, Norman M. Advanced maternal age increases the risk of very preterm birth, irrespective of parity: a population-based register study. BJOG 2016.</a></li><li><a class="nounderline abstract_t">Haslinger C, Stoiber B, Capanna F, et al. Postponed pregnancies and risks of very advanced maternal age. Swiss Med Wkly 2016; 146:w14330.</a></li><li><a class="nounderline abstract_t">Mathews TJ, Hamilton BE. Mean age of mother, 1970-2000. Natl Vital Stat Rep 2002; 51:1.</a></li><li><a class="nounderline abstract_t">Hamilton BE, Martin JA, Osterman MJ, et al. Births: Final Data for 2014. Natl Vital Stat Rep 2015; 64:1.</a></li><li><a class="nounderline abstract_t">Martin JA, Hamilton BE, Osterman MJK, et al. Births: Final Data for 2017. Natl Vital Stat Rep 2018; 67:1.</a></li><li><a class="nounderline abstract_t">Bacak SJ, Callaghan WM, Dietz PM, Crouse C. Pregnancy-associated hospitalizations in the United States, 1999-2000. Am J Obstet Gynecol 2005; 192:592.</a></li><li><a class="nounderline abstract_t">Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320:1708.</a></li><li><a class="nounderline abstract_t">Khalil A, Syngelaki A, Maiz N, et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2013; 42:634.</a></li><li><a class="nounderline abstract_t">Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278:1078.</a></li><li><a class="nounderline abstract_t">Savva GM, Walker K, Morris JK. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome). Prenat Diagn 2010; 30:57.</a></li><li><a class="nounderline abstract_t">Pettit KE, Hull AD, Korty L, et al. Noninvasive prenatal testing: a replacement for chorionic villus sampling and amniocentesis for advanced maternal age? Obstet Gynecol 2014; 123 Suppl 1:165S.</a></li><li><a class="nounderline abstract_t">Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004; 104:727.</a></li><li><a class="nounderline abstract_t">Joseph KS, Allen AC, Dodds L, et al. The perinatal effects of delayed childbearing. Obstet Gynecol 2005; 105:1410.</a></li><li class="breakAll">Centre for maternal and child enquiries (CMACE) perinatal mortality 2009. CMACE, London, 2011.</li><li class="breakAll">Pregnancy at Age 35 Years or Older. Obstetric Care Consensus No. 11. American College of Obstetricians and Gynecologists. Obstet Gynecol 2022;140:348–66.</li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326:1186.</a></li><li><a class="nounderline abstract_t">Reddy UM, Laughon SK, Sun L, et al. Prepregnancy risk factors for antepartum stillbirth in the United States. Obstet Gynecol 2010; 116:1119.</a></li><li><a class="nounderline abstract_t">Fox NS, Rebarber A, Silverstein M, et al. The effectiveness of antepartum surveillance in reducing the risk of stillbirth in patients with advanced maternal age. Eur J Obstet Gynecol Reprod Biol 2013; 170:387.</a></li><li class="breakAll">Dhanjal MK, Kenyon A. Induction of Labour at Term in Older Mothers. Scientific Impact Paper No. 34, Royal College of Obstetricians and Gynaecologists; London, UK, 2013.</li><li><a class="nounderline abstract_t">Page JM, Snowden JM, Cheng YW, et al. The risk of stillbirth and infant death by each additional week of expectant management stratified by maternal age. Am J Obstet Gynecol 2013; 209:375.e1.</a></li><li><a class="nounderline abstract_t">Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol 2006; 195:764.</a></li><li><a class="nounderline abstract_t">Hedegaard M, Lidegaard Ø, Skovlund CW, et al. Reduction in stillbirths at term after new birth induction paradigm: results of a national intervention. BMJ Open 2014; 4:e005785.</a></li><li><a class="nounderline abstract_t">Smith GC. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 2001; 184:489.</a></li><li><a class="nounderline abstract_t">Walker KF, Bugg GJ, Macpherson M, et al. Randomized Trial of Labor Induction in Women 35 Years of Age or Older. N Engl J Med 2016; 374:813.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists. ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries. Obstet Gynecol 2013; 121:911. Reaffirmed 2017.</a></li><li><a class="nounderline abstract_t">Gülmezoglu AM, Crowther CA, Middleton P, Heatley E. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev 2012; :CD004945.</a></li><li><a class="nounderline abstract_t">Middleton P, Shepherd E, Crowther CA. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev 2018; 5:CD004945.</a></li><li><a class="nounderline abstract_t">Grobman WA, Rice MM, Reddy UM, et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med 2018; 379:513.</a></li><li><a class="nounderline abstract_t">Walker KF, Malin G, Wilson P, Thornton JG. Induction of labour versus expectant management at term by subgroups of maternal age: an individual patient data meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016; 197:1.</a></li><li><a class="nounderline abstract_t">Nicholson JM, Kellar LC, Kellar GM. The impact of the interaction between increasing gestational age and obstetrical risk on birth outcomes: evidence of a varying optimal time of delivery. J Perinatol 2006; 26:392.</a></li></ol></div><div id="topicVersionRevision">Topic 454 Version 43.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27581343" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pregnancy at very advanced maternal age: a UK population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27770495" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Advanced maternal age increases the risk of very preterm birth, irrespective of parity: a population-based register study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27497045" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Postponed pregnancies and risks of very advanced maternal age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12564162" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mean age of mother, 1970-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26727629" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Births: Final Data for 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30707672" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Births: Final Data for 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15696008" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pregnancy-associated hospitalizations in the United States, 1999-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10864550" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Maternal age and fetal loss: population based register linkage study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23630102" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Maternal age and adverse pregnancy outcome: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9315766" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A prospective study of pregravid determinants of gestational diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19911411" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24770069" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Noninvasive prenatal testing: a replacement for chorionic villus sampling and amniocentesis for advanced maternal age?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15458893" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Advanced maternal age and adverse perinatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932837" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The perinatal effects of delayed childbearing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932837" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The perinatal effects of delayed childbearing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932837" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The perinatal effects of delayed childbearing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34581729" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20966697" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Prepregnancy risk factors for antepartum stillbirth in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23932303" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The effectiveness of antepartum surveillance in reducing the risk of stillbirth in patients with advanced maternal age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23932303" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The effectiveness of antepartum surveillance in reducing the risk of stillbirth in patients with advanced maternal age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23707677" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The risk of stillbirth and infant death by each additional week of expectant management stratified by maternal age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16949411" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Maternal age and the risk of stillbirth throughout pregnancy in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25125480" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Reduction in stillbirths at term after new birth induction paradigm: results of a national intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11228508" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26962902" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Randomized Trial of Labor Induction in Women 35 Years of Age or Older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635710" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22696345" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Induction of labour for improving birth outcomes for women at or beyond term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29741208" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Induction of labour for improving birth outcomes for women at or beyond term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30089070" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26686589" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Induction of labour versus expectant management at term by subgroups of maternal age: an individual patient data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16801956" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The impact of the interaction between increasing gestational age and obstetrical risk on birth outcomes: evidence of a varying optimal time of delivery.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
